IXC
Click for more information
0.00% 7.0¢ invex therapeutics ltd

The path to a Billion Dollar + company, page-69

  1. arkangel256
    335 Posts.
    lightbulb Created with Sketch. 147
    clock Created with Sketch.
    18/01/22
    15:35
    Post #: 58950813
    Three layers of protection:
    1. Patent protection in EU & US
    2. Orphan Drug Designation
    3. Invex owns the rights to Exenatide in pressure related conditions.

    There's no way a generic can cut into their market.
    IXC Price at posting: 70.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LU7 Filling the Lithium Conversion Gap: Lithium Universe commits to community collaboration through formation of joint committee for Bécancour
right-arrow Created with Sketch.
NEWS Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more
right-arrow Created with Sketch.
NOX Noxopharm aims for autoimmune market with first human trial of SOF-SKN
right-arrow Created with Sketch.
SUM Summit Minerals jumps 6% as LiDAR survey boosts confidence in niobium mineralisation
right-arrow Created with Sketch.
WR1 Stock watchers charged up by Winsome Resources' latest lithium drilling results
right-arrow Created with Sketch.
NEWS Good habits matters when it comes to finances
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $5.260M
Open High Low Value Volume
7.0¢ 7.0¢ 6.3¢ $5.263K 76.69K

Buyers (Bids)

No. Vol. Price($)
1 38879 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 8695 1
View Market Depth
Last trade - 13.14pm 20/08/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.